XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED BALANCE SHEETS (Q1) - USD ($)
Oct. 31, 2024
Aug. 01, 2024
Jul. 31, 2024
Oct. 31, 2023
Jul. 31, 2023
Nov. 04, 2022
Jul. 31, 2022
Current assets              
Cash $ 13,385   $ 21,106   $ 489,971    
GST receivable 95,556   85,658   49,408    
Prepaid expenses 31,433   35,141   311,690    
Total current assets 140,374   141,905   851,069    
Equipment 592   953   2,821    
Total assets 140,966   142,858   853,890    
Current liabilities              
Accounts payable and accrued liabilities 8,408,709   6,575,974   908,652    
Mandatory convertible debentures 0   127,500   0    
Convertible debentures 940,747   881,544   0    
Derivative liabilities 2,321,350 $ 1,382,096 919,250   0 $ 1,836,666  
Warrant laibilities 646,711   0        
Total current liabilities 12,317,517   8,504,268   908,652    
Shareholders' (deficiency)              
Common shares (No par value, unlimited common shares authorized; 29,603,123 SVS and 4,650,000 MVS issued and outstanding) (2023 - 28,419,790 SVS and 4,650,000 MVS) 0   0   0    
Additional paid in capital 13,561,064   13,321,266   11,883,289    
Accumulated other comprehensive loss 45,048   43,553   (83,570)    
Deficit (25,782,663)   (21,726,229)   (11,854,481)    
Total shareholders' equity (deficiency) (12,176,551)   (8,361,410) $ (2,781,466) (54,762)   $ 783,871
Total liabilities and shareholders' equity (deficiency) $ 140,966   $ 142,858   $ 853,890